Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.77 |
| ▸ | RAB9A | P51151 | 4/20 | 0.67 |
| ▸ | HPGD | P15428 | 3/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | NPC1 | O15118 | 3/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 3/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | ASAH1 | Q13510 | 2/20 | 0.55 |
| ▸ | DNMT3A | Q9Y6K1 | 1/20 | 0.52 |
| ▸ | MGAM | O43451 | 1/20 | 0.51 |
| ▸ | F2 | P00734 | 1/20 | 0.51 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | SI | P14410 | 1/20 | 0.51 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.51 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | STAT6 | P42226 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13844515 | 0.88 | KMT2A (0.75) | KMT2ARAB9AHPGDALDH1A1NPC1 | |
| SCHEMBL857765 | 0.83 | SMN1; SMN2 (0.61) | KMT2ARAB9AHPGDALDH1A1NPC1 | |
| SCHEMBL31229358 | 0.82 | KMT2A (0.55) | KMT2ARAB9AHPGDALDH1A1NPC1 | |
| SCHEMBL5440622 | 0.81 | KMT2A (0.54) | KMT2ARAB9AHPGDALDH1A1NPC1 | |
| SCHEMBL11443588 | 0.81 | KMT2A (0.60) | KMT2ARAB9AHPGDALDH1A1NPC1 | |
| SCHEMBL250172 | 0.81 | HTT (0.66) | KMT2ARAB9AHPGDALDH1A1NPC1 | |
| SCHEMBL5872635 | 0.79 | KMT2A (0.51) | KMT2ARAB9AHPGDALDH1A1NPC1 | |
| SCHEMBL5872634 | 0.79 | KMT2A (0.51) | KMT2ARAB9AHPGDALDH1A1NPC1 | |
| SCHEMBL28212537 | 0.79 | KMT2A (0.51) | KMT2ARAB9AHPGDALDH1A1NPC1 | |
| SCHEMBL3471303 | 0.79 | KMT2A (0.67) | KMT2ARAB9AHPGDALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 594 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117430738-A | Catalyst component for olefin polymerization, catalyst and application thereof | 中国石油化工股份有限公司 | 2024-01-23 | — | — | CN | claimed |
| CN-117430737-A | Catalyst component for olefin polymerization, catalyst and application thereof | 中国石油化工股份有限公司 | 2024-01-23 | — | — | CN | claimed |
| US-4542394-A | MULTILAYER-DIAZONIUM LAYER AND COUPLER LAYER CONTAINING BENZIMIDAZOLE COMPOUND | RICOH COMPANY, LTD. (JP) | 1985-09-17 | — | — | US | claimed |
| US-20240174583-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-05-30 | — | — | US | disclosed |
| EP-4347544-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | Dow Technology Investments LLC (US) | 2024-04-10 | — | — | EP | disclosed |
| CN-117430738-A | Catalyst component for olefin polymerization, catalyst and application thereof | 中国石油化工股份有限公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-117430737-A | Catalyst component for olefin polymerization, catalyst and application thereof | 中国石油化工股份有限公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-117242047-A | Process for the vapor phase hydrogenation of aldehydes | 陶氏技术投资有限责任公司 | 2023-12-15 | — | — | CN | disclosed |
| WO-2022250790-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2022-12-01 | — | — | WO | disclosed |
| EP-2970074-B1 | HYDROFORMYLATION PROVESS USING A HETEREOCYCLIC AGENT AS CATALYTIC STABILIZING AGENT | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2019-04-24 | — | — | EP | disclosed |
| CN-104045532-B | Hydroformylation process | 陶氏技术投资有限责任公司 | 2018-05-25 | — | — | CN | disclosed |
| WO-1995018206-A1 | PEROXYACID BLEACH PRECURSOR PARTICLE COATED WITH A WATER SOLUBLE ORGANIC ACID IN PARTICULATE FORM | THE PROCTER & GAMBLE COMPANY (US) | 1995-07-06 | — | — | WO | disclosed |
| EP-0659876-A2 | Detergent additive composition. | THE PROCTER & GAMBLE COMPANY (US) | 1995-06-28 | — | — | EP | disclosed |
| WO-1995012652-A1 | DETERGENT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1995-05-11 | — | — | WO | disclosed |
| WO-1995001416-A1 | MACHINE DISHWASHING COMPOSITION CONTAINING OXYGEN BLEACH AND PARAFFIN OIL AND BENZOTRIAZOLE COMPOUND SILVER TARNISHING INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 1995-01-12 | — | — | WO | disclosed |
| US-5001239-A | Formation of reissert compound of benzoyl benzimidazole | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 1991-03-19 | — | — | US | disclosed |
| US-5001239-A | Formation of reissert compound of benzoyl benzimidazole | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 1991-03-19 | — | — | US | disclosed |
| US-4542394-A | MULTILAYER-DIAZONIUM LAYER AND COUPLER LAYER CONTAINING BENZIMIDAZOLE COMPOUND | RICOH COMPANY, LTD. (JP) | 1985-09-17 | — | — | US | disclosed |
| US-4420479-A | 1-SUBSTITUTED, 2-AMINO-BENZIMIDAZOLES | ELI LILLY AND COMPANY (US) | 1983-12-13 | — | — | US | disclosed |
| EP-0091795-A1 | Olefinic benzimidazoles | ELI LILLY AND COMPANY (US) | 1983-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240174583-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | ADH1C, ADH5, ALDH2 | KMT2A 191/4885RAB9A 2415/4885HPGD 553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.